DIAGNOS Inc. provides data mining and interpretation consulting services, and designs data analytics software products. The Company operates through two segments: Healthcare and Natural resources. Its Healthcare segment offers image analysis services through Computer Assisted Retinal Analysis (CARA), a software tool, which assists health specialists in the detection of diabetic retinopathy. CARA is a hosted Web-based application that integrates fundus cameras with an image processing engine over an Internet connection. Its Natural resources segment offers data mining consulting services through Computer Aided Resource Detection System (CARDS), a software tool used to assist exploration companies in identifying mining deposits. In addition, it offers project management services. The Company operates in Canada, the United Arab Emirates, India, Mexico, Switzerland, the United States, Poland and Colombia.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolCVE:ADK
CUSIPN/A
Phone+1-450-6788882
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-58.07%
Return on EquityN/A
Return on Assets-90.29%
Miscellaneous
EmployeesN/A
Outstanding Shares172,421,000
Diagnos (CVE:ADK) Frequently Asked Questions
What is Diagnos' stock symbol?
Diagnos trades on the Canadian Venture Exchange (CVE) under the ticker symbol "ADK."
Who are some of Diagnos' key competitors?
Some companies that are related to Diagnos include Aveda Transportation (AVE), Energold Drilling (EGD), Abcourt Mines (ABI), Crown Point Energy (CWV), Alderon Iron Ore (ADV), Champion Bear Resources (CBA), Hyperion Exploration (HYX), Oceanic Iron (FEO), New Zealand Energy (NZ), North American Tungsten (NTC), Pinecrest Energy (PRY), Porto Energy (PEC), Arcan Resources (ARN), Canada Cobalt Works (CCW), Canamax Energy (CAC), Canopy Growth (CGC), Ceiba Energy Services (CEB) and Donnycreek Energy (DCK).
Who are Diagnos' key executives?
Diagnos' management team includes the folowing people:
- Georges L. Hebert, Chairman of the Board (Age 66)
- Andre Larente, President, Director
- Marc-Andre Massue, Chief Financial Officer, Vice President
- Guillermo Moreno Robles, Vice President - Health Care Business Development of Latin America
- Houssem Ben Tahar, Vice-President - Development and Business Intelligence
- Hadi Chakor, Chief Medical Officer
- Tristam Coffin, Director
- Jean-Yves Therien, Director
Has Diagnos been receiving favorable news coverage?
Media coverage about ADK stock has been trending somewhat positive recently, according to Accern Sentiment. The research group identifies negative and positive news coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Diagnos earned a daily sentiment score of 0.24 on Accern's scale. They also gave press coverage about the company an impact score of 46.98 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future.
How do I buy shares of Diagnos?
Shares of ADK and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Diagnos' stock price today?
One share of ADK stock can currently be purchased for approximately C$0.07.
How big of a company is Diagnos?
Diagnos has a market capitalization of C$14.66 million.
How can I contact Diagnos?
Diagnos' mailing address is 7005 Taschereau Blvd, Suite 340 Brossard, BROSSARD, QC J4Z 1A7, Canada. The company can be reached via phone at +1-450-6788882.
MarketBeat Community Rating for Diagnos (ADK)
MarketBeat's community ratings are surveys of what our community members think about Diagnos and other stocks. Vote "Outperform" if you believe ADK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ADK will underperform the S&P 500 over the long term. You may vote once every thirty days.
Diagnos (CVE:ADK) Analyst Ratings History
| Date | Brokerage | Action | Rating | Price Target | Details |
|---|
(Data available from 4/20/2016 forward)
Diagnos (CVE:ADK) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Diagnos (CVE ADK) Insider Trading and Institutional Ownership History
Diagnos (CVE ADK) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 2/2/2018 | Corporation Dundee | Insider | Sell | 2,026,000 | C$0.09 | C$182,340.00 | | |
(Data available from 1/1/2013 forward)
Diagnos (CVE ADK) News Headlines
| Source: |
|
Diagnos (CVE:ADK) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Diagnos (CVE ADK) Stock Chart for Friday, April, 20, 2018
Loading chart…
